135 related articles for article (PubMed ID: 37695550)
21. VISTA expression and patient selection for immune-based anticancer therapy.
Martin AS; Molloy M; Ugolkov A; von Roemeling RW; Noelle RJ; Lewis LD; Johnson M; Radvanyi L; Martell RE
Front Immunol; 2023; 14():1086102. PubMed ID: 36891296
[TBL] [Abstract][Full Text] [Related]
22. Expression and clinical significance of VISTA and PD-L1 in adrenocortical carcinoma.
Zhang Z; Li M; Wang J; Liu M; Chen H; Lou Y; Wang Y; Sun Q; Zhu D; Li P; Bi Y
Endocr Relat Cancer; 2022 May; 29(7):403-413. PubMed ID: 35521773
[TBL] [Abstract][Full Text] [Related]
23. Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma.
Kondo Y; Ohno T; Nishii N; Harada K; Yagita H; Azuma M
Oral Oncol; 2016 Jun; 57():54-60. PubMed ID: 27208845
[TBL] [Abstract][Full Text] [Related]
24. VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival.
Kuklinski LF; Yan S; Li Z; Fisher JL; Cheng C; Noelle RJ; Angeles CV; Turk MJ; Ernstoff MS
Cancer Immunol Immunother; 2018 Jul; 67(7):1113-1121. PubMed ID: 29737375
[TBL] [Abstract][Full Text] [Related]
25. Decreased Expression of Negative Immune Checkpoint VISTA by CD4+ T Cells Facilitates T Helper 1, T Helper 17, and T Follicular Helper Lineage Differentiation in GCA.
Hid Cadena R; Reitsema RD; Huitema MG; van Sleen Y; van der Geest KSM; Heeringa P; Boots AMH; Abdulahad WH; Brouwer E
Front Immunol; 2019; 10():1638. PubMed ID: 31379838
[TBL] [Abstract][Full Text] [Related]
26. Expression of VISTA on tumor-infiltrating immune cells correlated with short intravesical recurrence in non-muscle-invasive bladder cancer.
Seo WI; Lee CH; Jung SJ; Lee DS; Park HY; Jeong DH; Kim W; Chung JI; Choi I
Cancer Immunol Immunother; 2021 Nov; 70(11):3113-3122. PubMed ID: 33770210
[TBL] [Abstract][Full Text] [Related]
27. VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma.
He HX; Gao Y; Fu JC; Zhou QH; Wang XX; Bai B; Li PF; Huang C; Rong QX; Ping LQ; He YX; Mao JY; Chen X; Huang HQ
Oncoimmunology; 2021 Apr; 10(1):1907059. PubMed ID: 33889438
[TBL] [Abstract][Full Text] [Related]
28. VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes.
Ceeraz S; Eszterhas SK; Sergent PA; Armstrong DA; Ashare A; Broughton T; Wang L; Pechenick D; Burns CM; Noelle RJ; Vincenti MP; Fava RA
Arthritis Res Ther; 2017 Dec; 19(1):270. PubMed ID: 29216931
[TBL] [Abstract][Full Text] [Related]
29. Expression and Prognostic Value of B7 Family Immune Checkpoints in Pancreatic Neuroendocrine Tumors.
Mo S; Zong L; Chen X; Ban X; Li M; Lu Z; Yu S; Chen J
Arch Pathol Lab Med; 2023 Feb; 147(2):193-201. PubMed ID: 35671167
[TBL] [Abstract][Full Text] [Related]
30. Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma.
Wu L; Deng WW; Huang CF; Bu LL; Yu GT; Mao L; Zhang WF; Liu B; Sun ZJ
Cancer Immunol Immunother; 2017 May; 66(5):627-636. PubMed ID: 28236118
[TBL] [Abstract][Full Text] [Related]
31. High-Affinity Anti-VISTA Antibody Protects against Sepsis by Inhibition of T Lymphocyte Apoptosis and Suppression of the Inflammatory Response.
Tao T; Bo L; Li T; Shi L; Zhang H; Ye B; Xu Y; Ma Q; Deng X; Zhang G
Mediators Inflamm; 2021; 2021():6650329. PubMed ID: 34366711
[TBL] [Abstract][Full Text] [Related]
32. Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression.
Xu W; Dong J; Zheng Y; Zhou J; Yuan Y; Ta HM; Miller HE; Olson M; Rajasekaran K; Ernstoff MS; Wang D; Malarkannan S; Wang L
Cancer Immunol Res; 2019 Sep; 7(9):1497-1510. PubMed ID: 31340983
[TBL] [Abstract][Full Text] [Related]
33. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
34. Different clinical significance of novel B7 family checkpoints VISTA and HHLA2 in human lung adenocarcinoma.
Long L; Zhang L; Yang Y; Zhou Y; Chen H
Immunotherapy; 2022 Apr; 14(6):419-431. PubMed ID: 35187955
[No Abstract] [Full Text] [Related]
35. Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors.
Xie S; Huang J; Qiao Q; Zang W; Hong S; Tan H; Dong C; Yang Z; Ni L
Cancer Immunol Immunother; 2018 Nov; 67(11):1685-1694. PubMed ID: 30128738
[TBL] [Abstract][Full Text] [Related]
36. Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix.
Zong L; Zhang Q; Zhou Y; Kong Y; Yu S; Chen J; Zhang Y; Xiang Y
J Immunol Res; 2020; 2020():1283632. PubMed ID: 32322590
[TBL] [Abstract][Full Text] [Related]
37. VSIG-3 as a ligand of VISTA inhibits human T-cell function.
Wang J; Wu G; Manick B; Hernandez V; Renelt M; Erickson C; Guan J; Singh R; Rollins S; Solorz A; Bi M; Li J; Grabowski D; Dirkx J; Tracy C; Stuart T; Ellinghuysen C; Desmond D; Foster C; Kalabokis V
Immunology; 2019 Jan; 156(1):74-85. PubMed ID: 30220083
[TBL] [Abstract][Full Text] [Related]
38. Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses.
Liu J; Yuan Y; Chen W; Putra J; Suriawinata AA; Schenk AD; Miller HE; Guleria I; Barth RJ; Huang YH; Wang L
Proc Natl Acad Sci U S A; 2015 May; 112(21):6682-7. PubMed ID: 25964334
[TBL] [Abstract][Full Text] [Related]
39. Macrophage Differentiation and Polarization Regulate the Release of the Immune Checkpoint Protein V-Domain Ig Suppressor of T Cell Activation.
Noubissi Nzeteu GA; Schlichtner S; David S; Ruppenstein A; Fasler-Kan E; Raap U; Sumbayev VV; Gibbs BF; Meyer NH
Front Immunol; 2022; 13():837097. PubMed ID: 35634346
[TBL] [Abstract][Full Text] [Related]
40. Transcriptome profiling reveals transcriptional regulation of VISTA in T cell activation.
Yuan D; Zhang Y; Liu W; He X; Chen W; Liu L; Yang L; Wang Y; Wu Y; Liu J
Mol Immunol; 2023 May; 157():101-111. PubMed ID: 37004501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
